Sense Biodetection - About the company
Sense Biodetection is an acquired company based in Abingdon (United Kingdom), founded in 2014 by Harry Lamble. It operates as a Provider of point of care molecular diagnostics solutions. Sense Biodetection has raised $79.2M in funding from investors like Earlybird, Mercia and Koch Disruptive Technologies. The company has 59 active competitors, including 3 funded and 5 that have exited. Its top competitors include companies like Pictor, Curative and Aptitude Medical.
Company Details
Provider of point of care molecular diagnostics solutions. The company has Veros platform introduces novel and proprietary rapid molecular amplification technology to detect a variety of deadly and costly diseases. It commercialize Veros COVID-19 test, which delivers laboratory results directly to users.
- Website
- sense-bio.com
- Social
- Email ID
- *****@sense-bio.com
Key Metrics
Founded Year
2014
Location
Abingdon, United Kingdom
Stage
Acquired
Total Funding
$79.2M in 6 rounds
Latest Funding Round
Ranked
5th among 59 active competitors
Annual Revenue
£0 - £1M as on Dec 31, 2022
Employee Count
8 as on May 31, 2026
Exit Details
Acquired by Sherlock (Feb 01, 2023)
Legal entities associated with Sense Biodetection
Sense Biodetection is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
SENSEBIO HEALTH LIMITED CIN: 10122917 , United Kingdom, Active | Apr 12, 2016 | £0 - £1M (As on Apr 30, 2019) | - | |
Sense Biodetection Limited CIN: 8624309 , United Kingdom, Active | Jul 24, 2013 | £0 - £1M (As on Dec 31, 2022) | 43 (As on Jun 30, 2021) |
Sense Biodetection's acquisition details
Sense Biodetection got acquired by Sherlock on Feb 01, 2023.
Click here to take a look at Sense Biodetection's acquisition in detail
Sign up to download Sense Biodetection's company profile
Sense Biodetection's funding and investors
Sense Biodetection has raised a total funding of $79.2M over 6 rounds. Its first funding round was on Jun 08, 2016. Its latest funding round was a Series B round on Nov 17, 2021 for $*****. 1 investor participated in its latest round. Sense Biodetection has 8 institutional investors and 21 angel investors.
Here is the list of recent funding rounds of Sense Biodetection:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 17, 2021 | 9930206 | Series B | 1542941 | 2626040 | 4003251 | 6835250 |
Apr 20, 2021 | 8502677 | Series B | 6454684 | 9615879 | 4470257 | |
Oct 29, 2020 | 1446077 | Series B | 5165764 | 8162679 |
Access funding benchmarks and valuations. Sign up today!View details of Sense Biodetection's funding rounds and investors
Sense Biodetection's founders and board of directors
Founder? Claim ProfileThe founders of Sense Biodetection is Harry Lamble.
Here are the details of Sense Biodetection's key team members:
- Harry Lamble: Founder & Chief Business Development Officer of Sense Biodetection.
View details of Sense Biodetection's Founder profiles and Board Members
Sense Biodetection's employee count trend
Sense Biodetection has 8 employees as of May 26. Here is Sense Biodetection's employee count trend over the years:
Uncover Sense Biodetection's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sense Biodetection's Competitors and alternates
Top competitors of Sense Biodetection include Pictor, Curative and Aptitude Medical. Here is the list of Top 10 competitors of Sense Biodetection, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Pictor 2005, Auckland (New Zealand), Series A | Developer of immunodiagnostic products based on multiplexed assays | $11.1M | 60/100 | |
2nd |  Curative 2020, Austin (United States), Series B | Provider of self collecting COVID-19 testing centers listing platform | $162M | 57/100 | |
3rd |  Aptitude Medical 2011, Goleta (United States), Funding Raised | Democratizing diagnostics with accessible, lab-quality molecular testing solutions | - | 55/100 | |
4th | Developer of health care products for diagnosis and treatment | $4.5M | 45/100 | ||
5th | Sense Biodetection 2014, Abingdon (United Kingdom), Acquired | Provider of point of care molecular diagnostics solutions | $79.2M | 43/100 | |
6th |  Pearsanta 2023, Richmond (United States), Unfunded | Medical diagnostic and innovation company delivering personalized healthcare solutions | - | - | 42/100 |
7th | Provider of cell enrichment systems for cancer diagnosis and treatment | - | 41/100 | ||
8th |  Digital Diagnostics 2019, Mainz (Germany), Unfunded | Provider of AI-based real-time diagnostics devices for SARS-CoV-2 testing | - | - | 41/100 |
9th |  Rover Diagnostics 2018, New York City (United States), Funding Raised | Developer of portable PCR diagnostic devices for the diagnosis of infectious diseases | - | 39/100 | |
10th |  SQI Diagnostics 1999, Toronto (Canada), Public | Developer of multiplexed tests and automated systems for biological testing. | - | 35/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Sense Biodetection's competitors? Click here to see the top ones
Sense Biodetection's Investments and acquisitions
Sense Biodetection has made no investments or acquisitions yet.
Reports related to Sense Biodetection
Here is the latest report on Sense Biodetection's geography:
News related to Sense Biodetection
Filter this list•
Earlybird Health completes final close of £148m fundUKTN•Feb 14, 2024•Earlybird, Sikoia, Snyk, Sense Biodetection and 1 other
•
•
•
•
•
Sense Biodetection clinches Australia deal for Covid test platformBusiness Weekly newspaper•Oct 05, 2022•Sense Biodetection, Abacusdx
•
Sense and TECOmedical Sign Distribution Agreement for Germany, Austria, SwitzerlandBusiness Wire•Sep 01, 2022•TECOmedical, Sense Biodetection
•
•
Sense Appoints Michael Jones as Chief Financial OfficerBusiness Wire•Mar 29, 2022•Sense Biodetection
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Sense Biodetection
Explore our recently published companies
- Uvtcpl - India based, Unfunded company
- Diamondexch99 - Unfunded company
- Krishna's Herbal & Ayurveda - Jodhpur based, 2007 founded, Funding Raised company
- Dash - Atlanta based, 2025 founded, Unfunded company
- Bregma Science LLP - Bengaluru based, Unfunded company
- Nordible - Mumbai based, 2015 founded, Unfunded company
